HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab.
- DOI
- 10.1208/s12248-026-01244-9
- Published
- 2026-05-21
- Container
- AAPS J
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1208/s12248-026-01244-9,
title = {HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab.},
author = {Rajendran S and Gutierrez AH and Chien MS and Tang T and Gokemeijer J and Forman D and De Groot AS and Jawa V and Hamuro L.},
year = {2026},
journal = {AAPS J},
doi = {10.1208/s12248-026-01244-9},
url = {https://doi.org/10.1208/s12248-026-01244-9}
}RIS
TY - JOUR TI - HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab. AU - Rajendran S AU - Gutierrez AH AU - Chien MS AU - Tang T AU - Gokemeijer J AU - Forman D AU - De Groot AS AU - Jawa V AU - Hamuro L. PY - 2026 JO - AAPS J DO - 10.1208/s12248-026-01244-9 UR - https://doi.org/10.1208/s12248-026-01244-9 ER -
APA
S, R., AH, G., MS, C., T, T., J, G., D, F., AS, D. G., V, J., & L., H. (2026). HLA Class II Alleles DRB1*11:01 and DQB1*03:01 Unmask Immunogenetic Susceptibility to Anti-Nivolumab Antibodies in Combination with Ipilimumab.. AAPS J. https://doi.org/10.1208/s12248-026-01244-9
Source records
- europe-pmc · retrieved 2026-09-27T04:06:24.324Z